6R0H | pdb_00006r0h

Glycogen Phosphorylase b in complex with 3


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free: 
    0.213 (Depositor), 0.221 (DCC) 
  • R-Value Work: 
    0.159 (Depositor), 0.170 (DCC) 
  • R-Value Observed: 
    0.162 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 6R0H

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

High Consistency of Structure-Based Design and X-Ray Crystallography: Design, Synthesis, Kinetic Evaluation and Crystallographic Binding Mode Determination of Biphenyl-N-acyl-beta-d-Glucopyranosylamines as Glycogen Phosphorylase Inhibitors.

Fischer, T.Koulas, S.M.Tsagkarakou, A.S.Kyriakis, E.Stravodimos, G.A.Skamnaki, V.T.Liggri, P.G.V.Zographos, S.E.Riedl, R.Leonidas, D.D.

(2019) Molecules 24

  • DOI: https://doi.org/10.3390/molecules24071322
  • Primary Citation Related Structures: 
    6R0H, 6R0I

  • PubMed Abstract: 

    Structure-based design and synthesis of two biphenyl- N -acyl-β-d-glucopyranosylamine derivatives as well as their assessment as inhibitors of human liver glycogen phosphorylase (hlGPa, a pharmaceutical target for type 2 diabetes) is presented. X-ray crystallography revealed the importance of structural water molecules and that the inhibitory efficacy correlates with the degree of disturbance caused by the inhibitor binding to a loop crucial for the catalytic mechanism. The in silico-derived models of the binding mode generated during the design process corresponded very well with the crystallographic data.


  • Organizational Affiliation
    • Institute of Chemistry and Biotechnology, Center of Organic and Medicinal Chemistry, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland. thomas.fischer@zhaw.ch.

Macromolecule Content 

  • Total Structure Weight: 98.05 kDa 
  • Atom Count: 6,845 
  • Modeled Residue Count: 810 
  • Deposited Residue Count: 843 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Glycogen phosphorylase, muscle form843Oryctolagus cuniculusMutation(s): 0 
EC: 2.4.1.1
UniProt
Find proteins for P00489 (Oryctolagus cuniculus)
Explore P00489 
Go to UniProtKB:  P00489
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00489
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
JN2

Query on JN2



Download:Ideal Coordinates CCD File
B [auth A]3-(4-fluorophenyl)-~{N}-[(2~{R},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]benzamide
C19 H20 F N O6
ZNFXGMNTWYBCJQ-OGJJZOIMSA-N
PLP

Query on PLP



Download:Ideal Coordinates CCD File
C [auth A]PYRIDOXAL-5'-PHOSPHATE
C8 H10 N O6 P
NGVDGCNFYWLIFO-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free:  0.213 (Depositor), 0.221 (DCC) 
  • R-Value Work:  0.159 (Depositor), 0.170 (DCC) 
  • R-Value Observed: 0.162 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 128.287α = 90
b = 128.287β = 90
c = 116.12γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
CrysalisProdata reduction
Aimlessdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2019-04-10
    Type: Initial release
  • Version 1.1: 2019-04-24
    Changes: Data collection, Database references
  • Version 1.2: 2025-04-09
    Changes: Data collection, Database references, Structure summary